Linden Thomas Advisory Services, LLC

Position in LLY — ELI LILLY & Co

CIK 1965702 Charlotte, NC

Position in LLY

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$7,595,990

+$1,960,560 QoQ

Shares Held

6,333

+3.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

#1,420

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $22,830,139 across 6 Drug Manufacturers - General names. LLY ranks #1 (33.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	6,333	$7,595,990
2	ABBV	AbbVie Inc.	15,041	$3,784,917
3	GILD	Gilead Sciences, Inc.	27,150	$3,430,131
4	MRK	Merck & Co., Inc.	25,106	$3,226,121
5	AMGN	Amgen Inc	8,364	$3,028,771
6	BMY	Bristol Myers Squibb Co	30,618	$1,764,209

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,595,990	6,333	+3.4%	Shares	Sole	2026-07-16
2026-03-31	$5,635,430	6,127	+19.9%	Shares	Sole	2026-04-10
2025-12-31	$5,491,615	5,110	+2.9%	Shares	Sole	2026-01-16
2025-09-30	$3,790,584	4,968	+0.9%	Shares	Sole	2025-11-06
2025-06-30	$3,839,185	4,925	-36.6%	Shares	Sole	2025-07-31
2025-03-31	$6,420,624	7,774	+4.0%	Shares	Sole	2025-04-30
2024-12-31	$5,772,244	7,477	+4.7%	Shares	Sole	2025-01-21
2024-09-30	$6,327,383	7,142	+4.9%	Shares	Sole	2024-10-17
2024-06-30	$6,163,827	6,808	-16.6%	Shares	Sole	2024-07-10
2024-03-31	$6,348,931	8,161	-5.5%	Shares	Sole	2024-04-30
2023-12-31	$5,032,348	8,633	+6.4%	Shares	Sole	2024-02-01
2023-09-30	$4,358,809	8,115	-0.6%	Shares	Sole	2023-10-20
2023-06-30	$3,826,876	8,160	+6.0%	Shares	Sole	2023-07-27
2023-03-31	$2,642,960	7,696	+7.8%	Shares	Sole	2023-04-25
2022-12-31	$2,611,731	7,139	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.